What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Intellipharmaceutics International

Home
Canada
Toronto, ON
Intellipharmaceutics International

Intellipharmaceutics is engaged in the research, development, and commercialization of controlled-rel

11/11/2019

Intellipharmaceutics Announces Settlement Agreement in Class Action Lawsuit, Which is Subject to Court Approval

Download as PDF November 07, 2019 TORONTO, ONTARIO / ACCESSWIRE / November 7, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic c...

10/24/2019

Intellipharmaceutics Update on its Oxycodone ER New Drug Application

Download as PDF October 24, 2019 TORONTO, ON / ACCESSWIRE / October 24, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic control...

10/16/2019

Intellipharmaceutics Announces Third Quarter 2019 Results

https://www.intellipharmaceutics.com/news-media/press-releases/detail/211/intellipharmaceutics-announces-third-quarter-2019-results

Download as PDF October 11, 2019 TORONTO, ON / ACCESSWIRE / October 11, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic contr...

10/04/2019

Intellipharmaceutics Announces an Update in the Purdue Litigation

Download as PDF October 04, 2019 TORONTO, ONTARIO / ACCESSWIRE / October 4, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic contro...

09/05/2019

Intellipharmaceutics Signs a Second Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

Download as PDF September 05, 2019 TORONTO, ON / ACCESSWIRE / September 5, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and ge...

08/15/2019

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

Download as PDF August 15, 2019 TORONTO, ON / ACCESSWIRE / August 15, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic c...

07/24/2019

Intellipharmaceutics International Inc. Announces Update on its Oxycodone ER New Drug Application

https://www.intellipharmaceutics.com/news-media/press-releases/detail/207/intellipharmaceutics-international-inc-announces-update-on

Download as PDF July 24, 2019 TORONTO, ON / ACCESSWIRE / July 24, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the "Company,") a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-...

07/11/2019

Intellipharmaceutics Announces Second Quarter 2019 Results

https://www.intellipharmaceutics.com/news-media/press-releases/detail/206/intellipharmaceutics-announces-second-quarter-2019-results

Download as PDF July 10, 2019 TORONTO, ON / ACCESSWIRE / July 10, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic con...

07/09/2019

Intellipharmaceutics International Inc. Announces $10,000,000 Equity Financing Commitment
https://www.intellipharmaceutics.com/news-media/press-releases/detail/205/intellipharmaceutics-international-inc-announces

Download as PDF July 08, 2019 TORONTO, ON / ACCESSWIRE / July 8, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-r...

05/30/2019

Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada

Download as PDF May 30, 2019 TORONTO, ON / ACCESSWIRE / May 30, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-re...

Address

22 Worcester Road
Toronto, ON
M9W5X2

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+14167983001

Website

http://www.intellipharmaceutics.com/index.cfm

Alerts

Be the first to know and let us send you an email when Intellipharmaceutics International posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Intellipharmaceutics International:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Toronto?